Literature DB >> 1881617

Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptoms.

S Dacko1, J S Schneider.   

Abstract

The immunohistochemical localization of Met-enkephalin (Enk) was examined in the brains of normal monkeys (Macaca nemistrina), monkeys made parkinsonian by systemic MPTP administration and sacrificed while symptomatic, and monkeys exposed to low doses of MPTP over several months and sacrificed while asymptomatic for a gross parkinsonian motor disorder. The animals that had severe parkinsonian features had a large number of intensely Enk-immunoreactive perikarya in the putamen. Normal control animals had no Enk-immunoreactive perikarya while asymptomatic animals had small numbers of lightly to moderately stained perikarya in the putamen. Symptomatic animals also showed the most intense Enk immunoreactivity in the lateral globus pallidus (LGP) while the asymptomatic animals showed LGP Enk immunoreactivity intermediate between that seen in symptomatic and normal animals. These results suggest an increase in putamen Enk synthesis and LGP Enk content in animals with massive striatal dopamine depletions (greater than or equal to 97%) and which actively show parkinsonian features. Animals with slightly less striatal dopamine depletion and with no parkinsonian symptoms, had increased activity in this system but not to the extent seen in symptomatic animals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881617     DOI: 10.1016/0304-3940(91)90892-w

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors.

Authors:  A J Davis; M N Perkins
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  The actions of capsaicin applied topically to the skin of the rat on C-fibre afferents, antidromic vasodilatation and substance P levels.

Authors:  B Lynn; W Ye; B Cotsell
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

4.  Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.

Authors:  R J Vermeulen; B Drukarch; M C Sahadat; C Goosen; A N Schoffelmeer; E C Wolters; J C Stoof
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

5.  Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role.

Authors:  Hidetaka Koizumi; Ryoma Morigaki; Shinya Okita; Shinji Nagahiro; Ryuji Kaji; Masanori Nakagawa; Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2013-05-17       Impact factor: 5.505

6.  Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease.

Authors:  Lior Greenbaum; Mordechai Lorberboym; Eldad Melamed; Amihai Rigbi; Yael Barhum; Yoav Kohn; Alexander Khlebtovsky; Bernard Lerer; Ruth Djaldetti
Journal:  Front Neurosci       Date:  2013-04-15       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.